Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Total Debt (2016 - 2025)

Merit Medical Systems' Total Debt history spans 16 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Total Debt fell 98.33% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, down 98.33%, while the annual FY2025 figure was $12.2 million, 98.33% down from the prior year.
  • Total Debt for Q4 2025 was $12.2 million at Merit Medical Systems, down from $732.9 million in the prior quarter.
  • Across five years, Total Debt topped out at $823.4 million in Q4 2023 and bottomed at $12.2 million in Q4 2025.
  • The 5-year median for Total Debt is $306.4 million (2021), against an average of $442.0 million.
  • The largest annual shift saw Total Debt soared 2810.75% in 2023 before it crashed 98.33% in 2025.
  • A 5-year view of Total Debt shows it stood at $269.1 million in 2021, then tumbled by 89.49% to $28.3 million in 2022, then skyrocketed by 2810.75% to $823.4 million in 2023, then decreased by 11.36% to $729.9 million in 2024, then plummeted by 98.33% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Total Debt are $12.2 million (Q4 2025), $732.9 million (Q3 2025), and $731.8 million (Q2 2025).